Organigram Holdings | OGI - Gross Profit On Sales



Organigram Holdings reported CAD26.15M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Acasti Pharma USD 0 0 Mar/2022
Alaunos Therapeutics -1127000 1.11M Sep/2024
Aurora Cannabis CAD 27.95M 18.6M Jun/2025
Avita Medical AUD 16.13M 3.05M Dec/2024
Canopy Growth CAD 18.04M 6.06M Jun/2025
Cronos Group USD 14.5M 770K Jun/2025
Dianthus Therapeutics 193K 970K Jun/2025
Ionis Pharmaceuticals USD 448M 317.85M Jun/2025
IQVIA Holdings USD 1.05B 251M Jun/2025
Knight Therapeutics CAD 45.02M 2.32M Sep/2024
Moderna USD 18M 1000K Jun/2025
Organigram Holdings CAD 26.15M 25.1M Jun/2025
Organon & Co USD 874M 33M Jun/2025
Revvity USD 392.56M 17.01M Jun/2025
Tectonic Therapeutic 0 0 Mar/2025
Tilray USD 61.22M 1.51M Nov/2024
Viatris USD 1.33B 98.1M Jun/2025
Xeris Pharmaceuticals USD 59.64M 9.02M Jun/2025